Legal & General Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$243K Buy
84,260
+22,669
+37% +$57.6K ﹤0.01% 2530
2026
Q1
$121K Sell
61,591
-17,230
-22% -$40.4K ﹤0.01% 2593
2025
Q4
$214K Hold
78,821
﹤0.01% 2578
2025
Q3
$333K Hold
78,821
﹤0.01% 2537
2025
Q2
$393K Buy
78,821
+21,607
+38% +$93.8K ﹤0.01% 2509
2025
Q1
$252K Hold
57,214
﹤0.01% 2577
2024
Q4
$266K Hold
57,214
﹤0.01% 2629
2024
Q3
$397K Hold
57,214
﹤0.01% 2535
2024
Q2
$446K Hold
57,214
﹤0.01% 2454
2024
Q1
$406K Sell
57,214
-8,541
-13% -$56.5K ﹤0.01% 2508
2023
Q4
$441K Buy
65,755
+4,802
+8% +$27K ﹤0.01% 2506
2023
Q3
$343K Buy
60,953
+12,823
+27% +$85.5K ﹤0.01% 2580
2023
Q2
$266K Buy
48,130
+26,896
+127% +$145K ﹤0.01% 2674
2023
Q1
$133K Buy
21,234
+2,634
+14% +$14.7K ﹤0.01% 2716
2022
Q4
$86.7K Hold
18,600
﹤0.01% 2845
2022
Q3
$87K Sell
18,600
-13,026
-41% -$82.1K ﹤0.01% 2860
2022
Q2
$187K Buy
+31,626
New +$352K ﹤0.01% 2658

Other funds holding GDRX

Legal & General Group's GDRX Position: Q2 2026 in Review

Legal & General Group increased its GoodRx Holdings (GDRX) stake by 37% in Q2 2026, buying an estimated $57.6K and bringing the position to 84,260 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #2530.

Legal & General Group first reported a position in GDRX in Q2 2022 and has held it in 17 quarters since. The position peaked at $446K in Q2 2024. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Legal & General Group held 84,260 shares of GoodRx Holdings worth $243K as of Q2 2026.
  • Legal & General Group bought 22,669 GoodRx Holdings shares in Q2 2026, an estimated $57.6K.
  • GoodRx Holdings made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2530 holding.
  • Legal & General Group first reported a position in GoodRx Holdings in Q2 2022 and has held it in 17 quarters since.
  • Legal & General Group's GoodRx Holdings position peaked at $446K in Q2 2024.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.